BBOT is a private biotech company dedicated to developing innovative new therapeutics to address dire unmet needs in oncology. Founded on a commitment to patients, scientific excellence, and operational agility, we understand that every minute counts in our efforts to develop new therapies to transform the lives of people living with cancer. Driven by a team of experienced scientists, clinicians, and industry experts, our team utilizes cutting-edge structure-based drug discovery techniques to target some of oncology’s most challenging and validated molecular targets, including KRAS and PI3Ka. BBOT has a pipeline of several promising differentiated drug candidates and strong investor support, the combination of which positions us to deliver meaningful benefit to patients. Our offices and laboratory are in South San Francisco, though our colleagues and collaborators span the country and globe.
Who You Are:
This role will have primary responsibility for all medical aspects pertaining to assigned clinical studies in multiple oncology indications. This role works collaboratively with multi-disciplinary teams responsible for the design, implementation, monitoring, analysis, and reporting of studies conducted within the oncology portfolio to ensure the program meets the needs of patients and the business. This role will influence both internal and external audiences in a high-impact, prominent role as it actively contributes to the dynamic and innovative culture within BridgeBio.
Bridge Bio Oncology Therapeutics (BBOT) is a clinical-stage biopharmaceutical company focused on developing innovative small molecule therapeutics aimed at treating cancers associated with RAS and PI3K oncogenes. With a commitment to improving patient outcomes, BBOT has successfully secured $200 million in private financing to advance its next-generation pipeline. The company emphasizes precision medicine and operates within the oncology space, fostering a collaborative environment for its regulatory affairs team and other cross-functional teams.
Share This Job!
Save This Job!
Bridge Bio Oncology Therapeutics (BBOT) is a clinical-stage biopharmaceutical company focused on developing innovative small molecule therapeutics aimed at treating cancers associated with RAS and PI3K oncogenes. With a commitment to improving patient outcomes, BBOT has successfully secured $200 million in private financing to advance its next-generation pipeline. The company emphasizes precision medicine and operates within the oncology space, fostering a collaborative environment for its regulatory affairs team and other cross-functional teams.
Share This Job!
Save This Job!
The Chief of Staff will act as a strategic partner to the President, managing key initiatives and enhancing organizational alignment.
Beacons is looking for a Chief of Staff to support the CEO and lead strategic initiatives within the organization.
HousingPlus
HousingPlus
The Chief of Staff will support the CEO in strategic initiatives and internal coordination while fostering relationships across the organization.
The Chief of Staff will support the CEO in driving strategic initiatives and optimizing operations at Business Wire.
Terminal49 is seeking a Chief of Staff to support the COO and drive operational efficiency in a fast-paced startup environment.